Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing

Reproductive BioMedicine Online

Volumn 20, Issue 6, 2010, Pages 768-775

  Gleicher, Norbert ^a,b   Weghofer, Andrea ^a,c   Barad, David H ^a,d  

^a New York and Foundation for Reproductive Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anti M llerian hormone (AMH); FMR1 (fragile X) gene; Infertility; Ovarian reserve

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ALLELE; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FEMALE FERTILITY; GENE; GENE FUNCTION; GROUPS BY AGE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; OVARIAN RESERVE; RISK FACTOR;

EID: 77954309591     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.02.020     Document Type: Article

References (31)

1. Allen, E.G., Sullivan, A.K., Marcus, M., et al., 2007. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum. Reprod. 22, 2142-2152.
2. Bächner, D., Manca, A., Steinbach, P., et al., 1993. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests as special function in both the male and female gonad. Hum. Mol. Genet. 2, 2043-2050.
3. Barad, D.H., Weghofer, A., Gleicher, N., 2007. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet. Gynecol. 109, 1404-1410.
4. Barad, D.H., Weghofer, A., Gleicher, N., 2009. Comparing anti-Müllerian (AMH) and follicle stimulating (FSH) hormones as predictors of ovarian function. Fertil. Steril. 91, 1553-1555.
5. Bodega, B., Bione, S., Dalprà, L., et al., 2006. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestations. Hum. Reprod. 21, 952-957.
6. Bretherick, K.L., Fluker, M.R., Robinson, W.P., 2005. FMR1 repeat sizes in the gray zone and high end of normal range are associated with premature ovarian failure. Hum. Genet. 117, 376-382.
7. Chen, L.S., Yassone, F., Sahota, P., Hagermann, P.J., 2003. The (CGG)n repeat element within the 5'untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum. Mol. Genet. 12, 3067-3074.
8. Faddy, M.J., 2000. Follicle dynamics during ovarian ageing. Mol. Cell. Endocrinol. 163, 43-48.
9. Faddy, M.J., Gosden, R.G., 1995. A mathematical model of follicle dynamics in the human ovary. Hum. Reprod. 10, 770-775.
10. Faddy, M.J., Gosden, R.G., 1996. A model conforming the decline in follicle numbers to the age of menopause in women. Hum. Reprod. 11, 1484-1486.
11. Fu, Y.H., Kuhl, D.P., Pizzuti, A., et al., 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047-1058.
12. Gleicher, N., Weghofer, A., Barad, D.H., 2009a. A pilot study of premature ovarian senescence. I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil. Steril. 91, 1700-1706.
13. Gleicher, N., Weghofer, A., Barad, D.H., 2009b. A pilot study of premature ovarian senescence. II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil. Steril. 91, 1707-1711.
14. Gleicher, N., Weghofer, A., Oktay, K., Barad, D., 2009c. Releve-nace of low triple CGG repeats on the FMR1 gene to ovarian reserve. RBMOnline 19, 385-390.
15. Gleicher, N., Weghofer, A., Oktay, K., Barad, D.H., 2009d. Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation? Reprod. Sci. 16, 462-467.
16. Gleicher, N., Weghofer, A., Oktay, K., Barad, D.H., 2009e. Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause 16, 760-764.
17. Gleicher, N., Weghofer, A., Oktay, K., Barad, D.H., 2009f. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet. Gynecol. Scand. 88, 1024-1030.
18. Gleicher, N., Weghofer, A., Oktay, K., Barad, D.H., 2010. Effects of race/ethnicity on triple CGG counts on the FMR1 (fragile X) gene in infertile women Reprod. Biomed. online 20, 485-491.
19. Hundscheid, R.D.L., Braat, D.D.M., Kiemaney, L.A.L.M., Smits, A.P.T., Thomas, C.M.G., 2001. Increased serum FSH in female fragile X permutation carriers with either regular menstrual cycles or on oral contraceptives. Hum. Reprod. 16, 457-462.
20. Lorusso, F., Vicino, M., Lamanna, G., Trerotoli, P., Serio, G., Depalo, R., 2007. Performance of different ovarian reserve markers for predicting numbers of oocytes retrieved and mature oocytes. Maturitas 56, 429-435.
21. McConkie-Rosell, A., Abrams, L., Finucane, B., et al., 2007. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counselling for fragile X-associated disorders. J. Genet. Couns. 16, 593-606.
22. McConkie-Rosell, A., Finucane, B., Cronister, A., Abrams, L., Bennett, R.L., Pettersen, B.J., 2005. Genetic counselling for fragile X syndrome: updated recommendations of the national society of genetic counselors. J. Genet. Couns. 14, 249-270.
23. Murray, A., Ennis, S., MacSwiney, F., Webb, J., Morton, N.E., 2000. Reproductive and menstrual history of females with fragile X expansions. Eur. J. Hum. Genet. 8, 247-252.
24. Nikolaou, D., Templeton, A., 2004. Early ovarian ageing. Eur. J. Obstet. Gyecol. Reprod. Biol. 113, 126-133.
25. Practice Coomittee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. 2006. 2006 Guidelines for Gameter and Embryo Donation. Fertil. Steril., 86, S38-S50.
26. Rifé, M., Nadal, A., Mila, M., Willemsen, R., 2004. Immunohisto-chemical FMRP studies in full mutated female fetus. Am. J. Med. Genet. 124A, 129-132.
27. Rohr, J., Allen, E.G., Charen, K., et al., 2008. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) permutation carriers: a preliminary study. Hum. Reprod. 23, 1220-1225.
28. Singer, T., Barad, D.H., Weghofer, A., Gleicher, N., 2009. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil. Steril. 91, 2616-2619.
29. Tukey, J., 1977. Exploratory data analysis. In: Addison-Wesley Series in Behavioral Science. Quantitative Methods. Addison-Wesley, Reading, MA.
30. Welt, C.K., Smith, P.C., Taylor, A.E., 2004. Evidence of early ovarian aging in fragile X premutation carriers. J. Clin. Endocri-nol. Metab. 89, 4569-4574.
31. Wittenberger, M.D., Hagerman, R.J., Sherman, S.L., et al., 2007. The FMR1 premutation and reproduction. Fertil. Steril. 87, 456-465.